BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30391375)

  • 1. Application of modified histone peptide arrays in chromatin research.
    Mauser R; Jeltsch A
    Arch Biochem Biophys; 2019 Jan; 661():31-38. PubMed ID: 30391375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of mixed peptide arrays to study combinatorial readout of chromatin modifications.
    Mauser R; Kungulovski G; Meral D; Maisch D; Jeltsch A
    Biochimie; 2018 Mar; 146():14-19. PubMed ID: 29133117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity Analysis of Histone Modification-Specific Antibodies or Reading Domains on Histone Peptide Arrays.
    Kungulovski G; Kycia I; Mauser R; Jeltsch A
    Methods Mol Biol; 2015; 1348():275-84. PubMed ID: 26424280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity reagents for studying histone modifications & guidelines for their quality control.
    Kungulovski G; Mauser R; Jeltsch A
    Epigenomics; 2015 Oct; 7(7):1185-96. PubMed ID: 26541466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed specificity analysis of antibodies binding to modified histone tails with peptide arrays.
    Bock I; Dhayalan A; Kudithipudi S; Brandt O; Rathert P; Jeltsch A
    Epigenetics; 2011 Feb; 6(2):256-63. PubMed ID: 20962581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Celluspots peptide arrays for the analysis of the binding specificity of epigenetic reading domains to modified histone tails.
    Bock I; Kudithipudi S; Tamas R; Kungulovski G; Dhayalan A; Jeltsch A
    BMC Biochem; 2011 Aug; 12():48. PubMed ID: 21884582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Histone Antibody Specificity with Peptide Microarrays.
    Cornett EM; Dickson BM; Rothbart SB
    J Vis Exp; 2017 Aug; (126):. PubMed ID: 28809825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate Specificity Profiling of Histone-Modifying Enzymes by Peptide Microarray.
    Cornett EM; Dickson BM; Vaughan RM; Krishnan S; Trievel RC; Strahl BD; Rothbart SB
    Methods Enzymol; 2016; 574():31-52. PubMed ID: 27423856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From spots to beads-PTM-peptide bead arrays for the characterization of anti-histone antibodies.
    Heubach Y; Planatscher H; Sommersdorf C; Maisch D; Maier J; Joos TO; Templin MF; Poetz O
    Proteomics; 2013 Mar; 13(6):1010-5. PubMed ID: 23401470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput profiling of histone post-translational modifications and chromatin modifying proteins by reverse phase protein array.
    Wang X; Shi Z; Lu HY; Kim JJ; Bu W; Villalobos JA; Perera DN; Jung SY; Wang T; Grimm SL; Taylor BC; Rajapakshe K; Park H; Wulfkuhle J; Young NL; Li Y; Coarfa C; Edwards DP; Huang S
    J Proteomics; 2022 Jun; 262():104596. PubMed ID: 35489683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide microarrays to interrogate the "histone code".
    Rothbart SB; Krajewski K; Strahl BD; Fuchs SM
    Methods Enzymol; 2012; 512():107-35. PubMed ID: 22910205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of combinatorial histone modifications on antibody and effector protein recognition.
    Fuchs SM; Krajewski K; Baker RW; Miller VL; Strahl BD
    Curr Biol; 2011 Jan; 21(1):53-8. PubMed ID: 21167713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial profiling of chromatin binding modules reveals multisite discrimination.
    Garske AL; Oliver SS; Wagner EK; Musselman CA; LeRoy G; Garcia BA; Kutateladze TG; Denu JM
    Nat Chem Biol; 2010 Apr; 6(4):283-90. PubMed ID: 20190764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering and engineering chromodomain-methyllysine peptide recognition.
    Hard R; Li N; He W; Ross B; Mo GCH; Peng Q; Stein RSL; Komives E; Wang Y; Zhang J; Wang W
    Sci Adv; 2018 Nov; 4(11):eaau1447. PubMed ID: 30417094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A SPOT on the chromatin landscape? Histone peptide arrays as a tool for epigenetic research.
    Nady N; Min J; Kareta MS; Chédin F; Arrowsmith CH
    Trends Biochem Sci; 2008 Jul; 33(7):305-13. PubMed ID: 18538573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of dual reading domains as novel reagents in chromatin biology reveals a new H3K9me3 and H3K36me2/3 bivalent chromatin state.
    Mauser R; Kungulovski G; Keup C; Reinhardt R; Jeltsch A
    Epigenetics Chromatin; 2017 Sep; 10(1):45. PubMed ID: 28946896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of histone modification-specific interaction domains as an alternative to antibodies.
    Kungulovski G; Kycia I; Tamas R; Jurkowska RZ; Kudithipudi S; Henry C; Reinhardt R; Labhart P; Jeltsch A
    Genome Res; 2014 Nov; 24(11):1842-53. PubMed ID: 25301795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone code of Toxoplasma gondii comprises conserved and unique posttranslational modifications.
    Nardelli SC; Che FY; Silmon de Monerri NC; Xiao H; Nieves E; Madrid-Aliste C; Angel SO; Sullivan WJ; Angeletti RH; Kim K; Weiss LM
    mBio; 2013 Dec; 4(6):e00922-13. PubMed ID: 24327343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of the dynamics of histone modifications and their crosstalk using PTM-CrossTalkMapper.
    Kirsch R; Jensen ON; Schwämmle V
    Methods; 2020 Dec; 184():78-85. PubMed ID: 31978537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mass spectrometry-based assay using metabolic labeling to rapidly monitor chromatin accessibility of modified histone proteins.
    Sidoli S; Lopes M; Lund PJ; Goldman N; Fasolino M; Coradin M; Kulej K; Bhanu NV; Vahedi G; Garcia BA
    Sci Rep; 2019 Sep; 9(1):13613. PubMed ID: 31541121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.